Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $82.3000 (1.58%) ($80.9200 - $82.6000) on Mon. Feb. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.13% (three month average) | RSI | 24 | Latest Price | $82.3000(1.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(53%) DIA(52%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.565% in a week (0% probabilities). VIXM(-36%) VXX(-14%) TLT(-14%) IGOV(-5%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.565% (StdDev 1.13%) | Hourly BBV | 1.7 () | Intraday Trend | 1% | | | |
|
1 - 5 Day Possible Target | $77.03(-6.4%) | Resistance Level | $86.35 | 5 Day Moving Average | $82.41(-0.13%) | 10 Day Moving Average | $83.89(-1.9%) | 20 Day Moving Average | $86.35(-4.69%) | To recent high | -8.8% | To recent low | 1.6% | Market Cap | $145.201b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |